Cravath represented Mylan Inc. in connection with its $1.5 billion 144A/Reg. S senior notes offering. Mylan Inc. is a wholly owned subsidiary of Mylan N.V.,
Mylan NV is a global generic and specialty pharmaceuticals company. The Firm, led by Heather Bresch, Rajiv Malik and Kenneth S Parks, in 2017 recorded $11.907 Billion Revenues.
The transaction closed on April 9, 2018.
The Cravath team included partner Johnny G. Skumpija (Picture) and associates Alex M. Dzioba and Justin B. Stein on securities matters, and associate Kiran Sheffrin on tax matters. Jeffrey M. Amico also worked on securities matters.
Law Firms: Cravath Swaine & Moore;
Clients: Mylan, Inc.;